Clinical Trials Browser

Phase 3 × Disease Progression × 90 days × Clear all

NCT04987203 2026-05-08

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Phase 3 Completed

Carcinoma, Renal Cell, Disease Progression

NCT01191060 2026-04-06

IFM/DFCI2009

Phase 3 Completed

Disease Progression, Neoplasms, Plasma Cell

NCT06635447 2026-03-27

CAPItrue

Phase 3 Active not recruiting

Breast Neoplasms, Disease Progression